Medpace Holdings Stock Tumbles 17% On Q2 Earnings
Medpace Holdings Stock Tumbles 17% On Q2 Earnings
$Medpace (MEDP.US)$ shares are falling in Monday's after-hours session after the company reported mixed financial results and adjusted its forward guidance.
$Medpace (MEDP.US)$該公司發佈了混合的財務業績，並調整了向前的指導，導致股價下跌。
Q2 Revenue: $528.1 million, versus estimates of $528.44 million
Q2營業收入：5281萬美元，預估值爲5284萬美元。
Q2 EPS: $2.75, versus estimates of $2.54
Q2每股收益：2.75美元，預估值爲2.54美元。
Total revenue was up 14.6% on a year-over-year basis. Medpace said its backlog increased 13.7% year-over-year to $2.925 billion.
總營收同比增長14.6%。Medpace表示，在過去一年中，其積壓訂單增長了13.7%至29.25億美元。
The company generated $116.4 million in cash flow during the quarter. Medpace ended the quarter with $510.9 million in cash and cash equivalents.
該公司本季度現金流量爲1164萬美元。Medpace在本季度結束時，現金及現金等價物爲5,109萬美元。
Outlook: Medpace revised its full-year 2024 revenue forecast from a range of $2.15 billion to $2.2 billion to a new range of $2.125 billion to $2.175 billion versus estimates of $2.17 billion.
展望未來：Medpace將其2024全年營收預測從21.5億美元至22億美元的區間修訂爲新的區間21.25億美元至21.75億美元，預估值爲21.7億美元。
In contrast, Medpace raised its full-year 2024 earnings outlook from a range of $10.79 to $11.47 per share to a new range of $11.24 to $11.93 per share versus estimates of $11.25 per share.
相比之下，Medpace將其2024全年每股收益展望從10.79美元至11.47美元的區間調高至新的區間11.24美元至11.93美元，預估值爲每股11.25美元。